Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diabetic Monitoring Analyzers Are Small, Convenient, and Cost-Effective

By LabMedica International staff writers
Posted on 10 Mar 2010
Two analyzers were introduced to meet the growing global demand for improved management of diabetes.

Offering improved outcomes and reducing the healthcare burden, Quo-Test and Quo-Lab were developed to provide simplicity and performance at a low cost per test.

A single drop of blood from a finger prick sample is needed to provide HbA1c results in four minutes using the new analyzers. More...
HbA1C is a specific type of glycated hemoglobin, formed when glucose present in the blood attaches to hemoglobin. Whereas a blood glucose test can only measure what the blood glucose level is at the moment the test is done, an HbA1c test provides a way of assessing the average blood glucose level over the previous 6-8 weeks.

Globally recognized as the gold standard indicator of metabolic control of blood glucose, regular HbA1c monitoring helps minimize the long-term complications of diabetes, improve health outcomes, and reduce the escalating financial burden of the disease.

With full data connectivity and print options the newly introduced instruments deliver precise, accurate results wherever they are needed, in the laboratory or at the point of care (POC).

Quotient Diagnostics (Walton on Thames, UK) introduced the diabetic monitoring analyzers for the first time in the United Arab Emirates (a region where the disease is a major health issue) in January 2010 at the Arab Health exhibition in Dubai (UAE).

Diabetes is a major health issue in The United Arab Emirates, which has the second highest diabetes rate in the world. The disease is at the top of the agenda for the region's health professionals.

Related Links:

Quotient Diagnostics
Arab Health exhibition in Dubai




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.